Your browser is no longer supported. Please, upgrade your browser.
ICAD iCAD, Inc. weekly Stock Chart
ICAD [NASD]
iCAD, Inc.
Index- P/E- EPS (ttm)-0.77 Insider Own1.70% Shs Outstand18.11M Perf Week-9.67%
Market Cap157.38M Forward P/E- EPS next Y-0.34 Insider Trans0.00% Shs Float17.16M Perf Month9.72%
Income-13.50M PEG- EPS next Q-0.12 Inst Own31.00% Short Float3.98% Perf Quarter11.84%
Sales28.90M P/S5.45 EPS this Y-282.30% Inst Trans0.72% Short Ratio6.26 Perf Half Y31.67%
Book/sh0.42 P/B20.69 EPS next Y12.80% ROA-36.80% Target Price11.00 Perf Year50.35%
Cash/sh0.96 P/C9.04 EPS next 5Y15.00% ROE-177.40% 52W Range4.05 - 10.25 Perf YTD11.84%
Dividend- P/FCF- EPS past 5Y5.10% ROI-40.90% 52W High-15.22% Beta1.12
Dividend %- Quick Ratio1.60 Sales past 5Y-5.00% Gross Margin77.70% 52W Low114.57% ATR0.48
Employees95 Current Ratio1.80 Sales Q/Q27.40% Oper. Margin-24.80% RSI (14)52.77 Volatility7.17% 5.51%
OptionableYes Debt/Eq2.22 EPS Q/Q-87.50% Profit Margin-46.90% Rel Volume3.73 Prev Close9.01
ShortableYes LT Debt/Eq1.82 EarningsJan 29 BMO Payout- Avg Volume108.95K Price8.69
Recom1.70 SMA200.80% SMA5011.99% SMA20030.17% Volume406,892 Change-3.55%
Jan-09-20Initiated Lake Street Buy $14
Dec-09-08Reiterated Canaccord Adams Buy $5 → $3.50
Aug-01-08Reiterated MDB Capital Group Buy $5.50 → $6
May-14-08Reiterated Canaccord Adams Buy $4 → $4.50
Feb-14-08Initiated Sun Trust Rbsn Humphrey Buy $4
Jan-24-07Reiterated Dawson James Speculative Buy $4 → $5
Jan-13-20 08:00AM  iCAD Appoints Nathaniel Dalton to its Board of Directors GlobeNewswire
Jan-01-20 01:39PM  Is iCAD's (NASDAQ:ICAD) Share Price Gain Of 140% Well Earned? Simply Wall St.
Dec-20-19 06:23PM  Should You Avoid iCAD Inc (ICAD)? Insider Monkey
Dec-04-19 08:00AM  iCADs ProFound AI Joins Nuance AI Marketplace for Diagnostic Imaging GlobeNewswire
Dec-02-19 08:00AM  iCAD to Showcase Leading Breast Health Solutions Suite Including Expanded ProFound AI Platform at RSNA Annual Meeting GlobeNewswire
Nov-26-19 08:00AM  iCAD to Participate at the Piper Healthcare Conference GlobeNewswire
Nov-18-19 08:00AM  iCAD to Participate at the Cannacord Genuity Medtech & Diagnostics Forum GlobeNewswire
Nov-04-19 05:39PM  Edited Transcript of ICAD earnings conference call or presentation 30-Oct-19 12:30pm GMT Thomson Reuters StreetEvents
Oct-30-19 07:00AM  iCAD Reports Financial and Operating Results for the Third Quarter and Nine Months Ended September 30, 2019 GlobeNewswire -7.27%
Oct-28-19 10:58AM  iCAD, Inc. (NASDAQ:ICAD) Is Expected To Breakeven Simply Wall St.
Oct-24-19 08:00AM  iCAD to Report Third Quarter 2019 Financial Results on Wednesday, October 30 GlobeNewswire
Oct-07-19 08:00AM  ProFound AI Platform Featured at Journées Francophones de Radiologie Congress in Paris GlobeNewswire
Oct-01-19 08:00AM  iCAD Showcases ProFound AI Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest GlobeNewswire -5.11%
Sep-20-19 11:04AM  How Does Investing In iCAD, Inc. (NASDAQ:ICAD) Impact The Volatility Of Your Portfolio? Simply Wall St.
Sep-16-19 08:00AM  iCAD Exhibiting New Updates and Enhanced Xoft Platform at ASTRO Including Single-Fraction IORT Solution for the Treatment of Early-Stage Breast Cancer GlobeNewswire
Sep-10-19 08:00AM  iCADs ProFound AI Reader Study Published in Radiology: Artificial Intelligence GlobeNewswire +6.34%
Sep-04-19 08:00AM  iCADs ProFound AI Wins Best New Radiology Solution in 2019 MedTech Breakthrough Awards GlobeNewswire +5.13%
Sep-03-19 08:00AM  iCAD to Host Investor Meeting at ASTRO in Chicago GlobeNewswire
Aug-21-19 04:55PM  Edited Transcript of ICAD earnings conference call or presentation 1-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-15-19 01:11PM  iCAD (NASDAQ:ICAD) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Aug-13-19 12:45PM  ICAD: Q2 Results: ProFound AI Drives Detection Product Sales to ~8-year High. New Therapy Catalysts Emerge Zacks Small Cap Research
Aug-01-19 07:00AM  iCAD Reports Second Quarter 2019 Financial Results GlobeNewswire +7.22%
Jul-29-19 05:43PM  iCAD to Report Second Quarter 2019 Financial Results on Thursday, August 1 GlobeNewswire
Jul-11-19 08:00AM  iCADs ProFound AI for 2D Mammography Receives CE Mark Approval GlobeNewswire
Jul-10-19 02:21PM  What Percentage Of iCAD, Inc. (NASDAQ:ICAD) Shares Do Insiders Own? Simply Wall St. +7.48%
08:00AM  SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence GlobeNewswire
Jun-18-19 08:00AM  iCAD to Participate in the JMP Securities Life Sciences Conference and Piper Jaffray Heartland Summit GlobeNewswire
Jun-17-19 04:05PM  iCAD Announces Closing of Public Offering of Common Stock GlobeNewswire
Jun-13-19 08:00AM  iCAD Introduces ProFound AI for 2D Mammography in Europe GlobeNewswire
07:00AM  iCAD Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jun-12-19 04:16PM  iCAD Announces Proposed Public Offering of Common Stock GlobeNewswire
Jun-02-19 01:45AM  Edited Transcript of ICAD earnings conference call or presentation 7-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-15-19 10:00AM  ICAD: Therapy Buoys Q1 Sales, Benefits Operating Loss. Detection Acceleration Still Expected in 2H Zacks Small Cap Research +5.32%
May-07-19 11:06AM  Analysts Expect Breakeven For iCAD, Inc. (NASDAQ:ICAD) Simply Wall St.
08:10AM  Icad: 1Q Earnings Snapshot Associated Press
08:00AM  iCAD Reports First Quarter 2019 Financial Results GlobeNewswire
May-06-19 08:00AM  iCAD Appoints R. Scott Areglado as Chief Financial Officer GlobeNewswire
May-01-19 04:05PM  iCAD to Report First Quarter 2019 Financial Results on Tuesday, May 7 GlobeNewswire
Apr-15-19 08:00AM  iCAD Wins Three-System Public Bid with Leading Cancer Organization in Spain, Expanding European Access to Innovative Cancer Treatments with the Xoft System GlobeNewswire
Apr-04-19 10:53AM  iCAD to Highlight ProFound AI Solution for Digital Breast Tomosynthesis at 2019 Society of Breast Imaging Annual Symposium GlobeNewswire +11.89%
Mar-29-19 06:48PM  icad Inc (ICAD) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com +6.82%
Mar-28-19 08:22AM  iCAD Appoints Stacey Stevens as President GlobeNewswire +5.91%
Mar-26-19 08:00AM  iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit GlobeNewswire
Mar-25-19 10:10AM  ICAD: ProFound AI Makes U.S. Debut, Roll-Out Accelerating. More AI Products Could Soon Follow Zacks Small Cap Research +6.05%
Mar-21-19 04:43AM  Edited Transcript of ICAD earnings conference call or presentation 18-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-18-19 04:18PM  Icad: 4Q Earnings Snapshot Associated Press
04:01PM  iCAD Reports Fourth Quarter and Full-Year 2018 Financial Results GlobeNewswire
02:30PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
Mar-14-19 05:29PM  iCAD Reports Strong Momentum of ProFound AI, its Artificial Intelligence-Based Solution for Digital Breast Tomosynthesis Business Wire
08:00AM  iCAD to Present Corporate Overview at the 31st Annual ROTH Conference GlobeNewswire
Mar-13-19 04:30PM  iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18 GlobeNewswire
Feb-27-19 04:30PM  iCAD to Partner with Leading Breast Cancer Researchers from Karolinska Institutet to Develop Artificial Intelligence-Based Breast Cancer Risk Prediction Solution GlobeNewswire
Feb-21-19 11:12AM  iCAD to Showcase ProFound AI Solution for Digital Breast Tomosynthesis at ECR 2019 GlobeNewswire
Jan-07-19 08:00AM  Long-Term Study of 1,000 Tumors Demonstrates Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire +9.60%
Jan-03-19 07:00AM  Arcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer GlobeNewswire
Dec-27-18 04:01PM  iCAD Announces CFO Transition GlobeNewswire
Dec-20-18 07:00AM  iCAD, Inc. Announces $7.0 Million Private Placement of Unsecured Subordinated Convertible Debentures GlobeNewswire
Dec-13-18 06:28PM  Edited Transcript of ICAD earnings conference call or presentation 13-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Dec-07-18 08:00AM  iCAD Announces FDA Clearance of ProFound AI for Digital Breast Tomosynthesis GlobeNewswire -5.84%
Nov-27-18 01:50PM  ICAD: Confident of FDA Approval of Tomo 2.0 (i.e. ProFound AI). New/Interim CEO Looks Like Perfect Fit Zacks Small Cap Research
Nov-26-18 12:21PM  iCAD Unveils ProFound AI for Digital Breast Tomosynthesis at RSNA 2018 GlobeNewswire
Nov-15-18 09:30AM  How Financially Strong Is iCAD Inc (NASDAQ:ICAD)? Simply Wall St.
Nov-13-18 04:18PM  Icad: 3Q Earnings Snapshot Associated Press +10.63%
04:01PM  iCAD Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-09-18 08:53AM  iCAD Announces Retirement of CEO, Ken Ferry GlobeNewswire
Nov-06-18 04:05PM  iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th GlobeNewswire
Oct-30-18 08:00AM  Navicent Health Adopts iCADs Breast Cancer Detection and Therapy Solutions to Enhance Patient Care GlobeNewswire
Oct-23-18 02:01PM  iCAD Announces New Clinical Data on the Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment Demonstrating Positive Results GlobeNewswire
Oct-11-18 08:00AM  iCAD Announces Exceptional Study Results Demonstrating Significant Advantages of Revolutionary Artificial Intelligence Technology for Digital Breast Tomosynthesis GlobeNewswire +8.31%
Oct-09-18 08:00AM  SUNY Upstate Medical University Selects iCADs Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire
Oct-03-18 08:00AM  Sanford Health Announces Adoption of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire
Oct-01-18 02:35PM  Independent, Long-Term Study Highlights Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire
Sep-20-18 11:24AM  iCAD Inc (NASDAQ:ICAD): Risks You Need To Consider Before Buying Simply Wall St.
Sep-04-18 11:15AM  ICAD: U.S. Tomo 2.0, Organic Therapy Growth and Leaner Ops Mean Profitability is Realistic Zacks Small Cap Research
Aug-31-18 08:07AM  Edited Transcript of ICAD earnings conference call or presentation 14-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-29-18 08:00AM  iCAD Announces AERB Approval of Xoft System in India GlobeNewswire
Aug-28-18 08:00AM  Medical City Plano, a HCA Healthcare Facility, Adopts iCADs Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer GlobeNewswire
07:00AM  Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer GlobeNewswire
Aug-14-18 04:13PM  Icad: 2Q Earnings Snapshot Associated Press
04:01PM  iCAD Reports Second Quarter 2018 Financial Results GlobeNewswire
Aug-08-18 09:14AM  ICAD's stock soars after FDA clearance of breast-density AI software product MarketWatch +7.77%
08:00AM  iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis GlobeNewswire
Aug-07-18 08:00AM  iCAD to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Tuesday, August 14th GlobeNewswire
Jun-26-18 01:57PM  What Does iCAD Incs (NASDAQ:ICAD) Share Price Indicate? Simply Wall St.
Jun-06-18 08:00AM  iCAD Named 2018 MedTech Breakthrough Award Winner GlobeNewswire
May-22-18 09:20AM  ICAD: Q1 2018 Results: Detection Disappointing But Still Looking For 2.0-Related Inflection in 2H Zacks Small Cap Research
May-21-18 10:03PM  Edited Transcript of ICAD earnings conference call or presentation 14-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-14-18 04:39PM  Icad: 1Q Earnings Snapshot Associated Press
04:01PM  iCAD Reports First Quarter 2018 Financial Results GlobeNewswire
12:15PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
09:55AM  iCAD Inc (NASDAQ:ICAD): Time For A Financial Health Check Simply Wall St.
May-08-18 08:00AM  iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018 GlobeNewswire
Apr-19-18 08:00AM  iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37 GlobeNewswire
Apr-12-18 07:40AM  Free Post Earnings Research Report: Nutanixs Revenues Surged 44%; Net Loss Narrowed ACCESSWIRE
Apr-03-18 09:45AM  ICAD: Q4 2017 Results: Tomo Seeing Strong Demand. Plug Pulled on Unprofitable Skin Subscription Biz Zacks Small Cap Research
Mar-23-18 07:21PM  Edited Transcript of ICAD earnings conference call or presentation 22-Mar-18 8:30pm GMT Thomson Reuters StreetEvents
07:23AM  3 Stocks to Watch on Friday: At Home Group Inc (HOME), HTG Molecular Diagnostics Inc (HTGM) and iCAD Inc (ICAD) InvestorPlace
Mar-22-18 04:01PM  iCAD Reports Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
01:00PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
Mar-16-18 08:00AM  iCAD to Report Fourth Quarter and Fiscal 2017 Financial Results on Thursday, March 22, 2018 GlobeNewswire
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy. The company provides electronic brachytherapy (eBX) products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, cervical cancer, and skin cancer, as well as for treating other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy. It also offers digital mammography computer-aided detection (CAD) products, which include PowerLook Mammo Detection, which detects and identifies suspicious masses and micro-calcifications; and PowerLook Platform, a server residing on a customer's network that receives patient studies from the imaging modality, performs analysis, and sends results to picture archiving and communication system and/or review workstations. In addition, the company offers magnetic resonance imaging products to detect breast and prostate cancer; breast tomosynthesis systems; and advanced image analysis and workflow solutions in computed tomography (CT) colonography, including VeraLook that supports the detection of colonic polyps in conjunction with CT colonography. It serves healthcare centers through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was founded in 1984 and is headquartered in Nashua, New Hampshire.